Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 2
2014 1
2015 5
2016 3
2017 1
2018 2
2019 4
2020 4
2021 2
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
Early-Life Microbial Restitution Reduces Colitis Risk Promoted by Antibiotic-Induced Gut Dysbiosis in Interleukin 10-/- Mice.
Miyoshi J, Miyoshi S, Delmont TO, Cham C, Lee STM, Sakatani A, Yang K, Shan Y, Kennedy M, Kiefl E, Yousef M, Crosson S, Sogin M, Antonopoulos DA, Eren AM, Leone V, Chang EB. Miyoshi J, et al. Among authors: sakatani a. Gastroenterology. 2021 Sep;161(3):940-952.e15. doi: 10.1053/j.gastro.2021.05.054. Epub 2021 Jun 7. Gastroenterology. 2021. PMID: 34111469 Free PMC article.
Intraductal cholangioscopic visualization of moving Fasciola hepatica.
Fujibayashi S, Goto T, Sasajima J, Utsumi T, Dokoshi T, Sakatani A, Tanaka K, Nomura Y, Ueno N, Kashima S, Inaba Y, Moriichi K, Fujiya M, Kohgo Y. Fujibayashi S, et al. Among authors: sakatani a. Gastrointest Endosc. 2015;81(6):1485-6. doi: 10.1016/j.gie.2014.12.014. Epub 2015 Mar 29. Gastrointest Endosc. 2015. PMID: 25825315 No abstract available.
Concomitant pharmacologic medications influence the clinical outcomes of granulocyte and monocyte adsorptive apheresis in patients with ulcerative colitis: A multicenter retrospective cohort study.
Ueno N, Sugiyama Y, Kobayashi Y, Murakami Y, Iwama T, Sasaki T, Kunogi T, Sakatani A, Takahashi K, Tanaka K, Serikawa S, Ando K, Kashima S, Muto M, Inaba Y, Moriichi K, Tanabe H, Okumura T, Fujiya M. Ueno N, et al. Among authors: sakatani a. J Clin Apher. 2023 Aug;38(4):406-421. doi: 10.1002/jca.22040. Epub 2023 Jan 13. J Clin Apher. 2023. PMID: 36636880
[The task of the medical cooperation system for patients with inflammatory bowel disease in the northern and eastern regions of Hokkaido].
Sato M, Ueno N, Sugimura K, Iwama T, Tanaka K, Sakatani A, Serikawa S, Ando K, Kashima S, Ishikawa C, Muto M, Inaba Y, Moriichi K, Tanabe H, Okumura T, Fujiya M. Sato M, et al. Among authors: sakatani a. Nihon Shokakibyo Gakkai Zasshi. 2023;120(7):590-601. doi: 10.11405/nisshoshi.120.590. Nihon Shokakibyo Gakkai Zasshi. 2023. PMID: 37423730 Japanese.
The safety of vedolizumab in a patient with Crohn's disease who developed anti-TNF-alpha agent associated latent tuberculosis infection reactivation: A case report.
Sugiyama Y, Ueno N, Tachibana S, Kobayashi Y, Murakami Y, Sasaki T, Sakatani A, Takahashi K, Ando K, Kashima S, Moriichi K, Tanabe H, Okumura T, Fujiya M. Sugiyama Y, et al. Among authors: sakatani a. Medicine (Baltimore). 2023 Jul 14;102(28):e34331. doi: 10.1097/MD.0000000000034331. Medicine (Baltimore). 2023. PMID: 37443475 Free PMC article.
28 results